Funding This study was supported by the Medical Health Science and technology Project of Zhejiang Province (2024KY881), Zhejiang Clinovation Pride (CXTD202-501010), Zhejiang Provincial Department of Science and Technology Research Institute Support Program (KJTYSZX2025), and State Administration of Traditional Chinese Medicine Science and Technology Department-Zhejiang Provincial Administration of Traditional Chinese Medicine Co-construction of Key Laboratory of Research on Prevention and Treatment for Depression Syndrome (GZY-ZJ-SY-2402)
We would love to hear from you.
Upon exclusion of the ELIXA trial which utilized the short-acting GLP-1RA lixisenatide and was associated with neutral CV outcomes the relative risk reduction improved to 15% (HR, 0.85
Disulfide high mobility group box-1 dose-dependently increases the phosphorylation of Tyr 1472 of NR2B and enhances the expression of toll-like receptor 4 (TLR4), which is associated with permeability of Ca 2+ channels in hippocampal neurons [45]
For instance, some studies have linked GLP-1 use to a lower risk of hypertensive disorders of pregnancy
Melanotan II emerged as a cyclic analog with broad receptor activity
